| P50 | author | Giorgos Kollias | Q11260534 |
| | Hans Lassmann | Q35704729 |
| | Manolis Pasparakis | Q39961401 |
| | Katerina Akassoglou | Q55477572 |
| P2093 | author name string | Bauer J | |
| | Probert L | |
| | Kassiotis G | |
| P2860 | cites work | Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis | Q28293364 |
| | Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes | Q28593744 |
| | Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice | Q28593915 |
| | Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune re | Q28594116 |
| | An essential role for NF-kappaB in preventing TNF-alpha-induced cell death | Q29614707 |
| | Suppression of TNF-alpha-induced apoptosis by NF-kappaB | Q29618717 |
| | Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death | Q29620021 |
| | Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific | Q33336314 |
| | Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin | Q33393620 |
| | The longstanding MS lesion. A quantitative MRI and electron microscopic study | Q33638573 |
| | Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha | Q33771960 |
| | Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. | Q33900383 |
| | The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis | Q34720182 |
| | Immunological aspects of demyelinating diseases | Q35319665 |
| | Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. | Q35769109 |
| | Astrocytes induce blood–brain barrier properties in endothelial cells | Q57318253 |
| | Patterns of oligodendroglia pathology in multiple sclerosis | Q61709808 |
| | Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques | Q61709815 |
| | Animal models | Q61709827 |
| | Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor | Q67267330 |
| | Persistent anti-myelin basic protein IgG antibody response in multiple sclerosis cerebrospinal fluid | Q67665088 |
| | Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro | Q70392550 |
| | Cytokine expression of macrophages in HIV-1-associated vacuolar myelopathy | Q70714392 |
| | Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors | Q71169977 |
| | Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis | Q71607261 |
| | Differential Oligodendroglial Expression of the Tumor Necrosis Factor Receptors In Vivo and In Vitro | Q71832510 |
| | Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins | Q72194401 |
| | Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I | Q72556715 |
| | Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia | Q73323440 |
| | ICE/CED-3 family executes oligodendrocyte apoptosis by tumor necrosis factor | Q73456871 |
| | Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions | Q35819856 |
| | The pathophysiology of tumor necrosis factors | Q36135208 |
| | An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis | Q36353675 |
| | Tumor necrosis factor identified in multiple sclerosis brain | Q36356662 |
| | Activation and homologous desensitization of human endothelial cells by CD40 ligand, tumor necrosis factor, and interleukin 1. | Q36367016 |
| | Mechanisms of cytokine-mediated localized immunoprotection | Q36367596 |
| | Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling | Q36377176 |
| | Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis. | Q36377351 |
| | Multiple sclerosis: Fas signaling in oligodendrocyte cell death | Q36377383 |
| | A critical role for lymphotoxin in experimental allergic encephalomyelitis | Q36380767 |
| | Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting | Q36380828 |
| | Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. | Q36437643 |
| | Heightened expression of tumor necrosis factor alpha, interleukin 1 alpha, and glial fibrillary acidic protein in experimental Creutzfeldt-Jakob disease in mice | Q37362557 |
| | Multiple sclerosis: a pivotal role for the T cell in lesion development | Q37485436 |
| | The T lymphocyte in experimental allergic encephalomyelitis | Q37925549 |
| | Multiple sclerosis: TNF revisited, with promise | Q40429865 |
| | Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison | Q40926622 |
| | The central nervous system as an immunocompetent organ: role of glial cells in antigen presentation | Q41075467 |
| | Cytokines in inflammatory brain lesions: helpful and harmful | Q41141050 |
| | Effects of Interleukin-1 and Tumor Necrosis Factor-α on Astrocytes, Microglia, Oligodendrocytes, and Glial Precursors in vitro | Q41144540 |
| | Mechanisms of immune injury in multiple sclerosis | Q41157659 |
| | Cell death induction by receptors of the TNF family: towards a molecular understanding. | Q41554119 |
| | Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain | Q41778413 |
| | Some misconceptions about understanding autoimmunity through experiments with knockouts | Q42931515 |
| | Vacuolar myelopathy with multinucleated giant cells in the acquired immune deficiency syndrome (AIDS). Light and electron microscopic distribution of human immunodeficiency virus (HIV) antigens | Q43519961 |
| | Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis | Q43876866 |
| | In situ hybridization with digoxigenin-labeled probes: sensitive and reliable detection method applied to myelinating rat brain | Q44203392 |
| | Glial cell differentiation in neuron-free and neuron-rich regions. I. Selective appearance of S-100 protein in radial glial cells of the hippocampal fimbria in human fetuses | Q44728444 |
| | The balance between persistent virus infection and immune cells determines demyelination. | Q45765875 |
| | In vitro evidence for a dual role of tumor necrosis factor‐α in human immunodeficiency virus type 1 encephalopathy | Q45786587 |
| | Late complications of immune deviation therapy in a nonhuman primate | Q46594595 |
| | Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis | Q48048028 |
| | Oligodendrocytes in the early course of multiple sclerosis | Q48196640 |
| | Ultrastructure of multiple sclerosis | Q48200908 |
| | Interactions between oligodendrocytes and microglia. A major role for complement and tumour necrosis factor in oligodendrocyte adherence and killing | Q48397929 |
| | Expression of leucocyte adhesion molecules at the human blood-brain barrier (BBB). | Q48541795 |
| | Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice | Q48825088 |
| | Cell death during autoimmune demyelination: effector but not target cells are eliminated by apoptosis. | Q51995260 |
| | TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. | Q54150165 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| | nervous system | Q9404 |
| | oligodendrocyte | Q916698 |
| | multiple sclerosis | Q8277 |
| | TNF | Q18032037 |
| P304 | page(s) | 801-813 | |
| P577 | publication date | 1998-09-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy | |
| P478 | volume | 153 | |